Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.41M.
ENTERPRISE VALUE (EV)
$1.41M
Aspire Biopharma Holdings, Inc.
Market Cap
$1.03M
Enterprise Value (EV)
$1.41M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.03M | $1.41M |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | $2.13M |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | $9.68M |
| GlucoTrack, Inc. (GCTK)vs › | $877957.00 | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | $853205.00 |
| Bone Biologics Corporation (BBLG)vs › | $873327.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $861788.00 | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | $1.43M |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $834083.00 | N/A |
Market Cap
$1.03M
Total Debt
$1.38M
Cash
$1.00M
Enterprise Value
$1.41M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
